Author Correction: Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trial
O
Oscar Arrieta
L
Luis Lara-Mejía
E
Eduardo Rios-Garcia
E
Enrique Caballé-Perez
L
Luis Cabrera-Miranda
M
Maritza Ramos-Ramírez
D
David Dávila-Dupont
A
Andrés F. Cardona
G
Graciela Cruz-Rico
J
Jordi Remon
A
Alexandra Garcilazo-Reyes
R
Rafael Rosell
Article Details
Journal
Nature Communications
Volume / Issue
Vol. 16, Issue 1
Published
December 12, 2025
ISSN
2041-1723
Publisher
Nature Portfolio
Authors (12)
O
Oscar Arrieta
L
Luis Lara-Mejía
E
Eduardo Rios-Garcia
E
Enrique Caballé-Perez
L
Luis Cabrera-Miranda
M
Maritza Ramos-Ramírez
D
David Dávila-Dupont
A
Andrés F. Cardona
G
Graciela Cruz-Rico
J
Jordi Remon
A
Alexandra Garcilazo-Reyes
R
Rafael Rosell
Related Articles from this Journal
Synthesis of adaptive 15N-nitrosyl-Co7 nanocluster for electrocatalytic C–H functionalization
Chao Wu, Xu Zhang et al.
Aug 2026
10.1038/s41467-026-76516-1
Pan-Ebolavirus nanoparticle vaccine provides protection in rodents from lethal infection by Zaire and Sudan viruses
Connor Weidle, Natalie Brunette et al.
Aug 2026
10.1038/s41467-026-76114-1
Multi-population GWAS meta-analysis identifies bladder cancer susceptibility loci and highlights genetic regulation of smoking-related risk
Ludmila Prokunina-Olsson, Oscar Florez-Vargas et al.
Aug 2026
10.1038/s41467-026-76157-4
Genome-wide annotation of human multi-nucleotide variants reveals widespread functional differences from single nucleotide variants
Weiwei Jin, Wen Cao et al.
Aug 2026
10.1038/s41467-026-76470-y
Allele-specific chromatin architecture shapes imprinted domains and coordinates a distal enhancer and antisense transcription at the mouse Mest-Copg2 domain
Bongmin Bae, Katherine Gu et al.
Aug 2026
10.1038/s41467-026-76506-3